Humanigen Inc (HGENQ)

[DonDonDonDon]

The EUA for early stage severe patients should come within a month. But that is just the start. Patients who eventually become severe and die show elevated GM-CSF in the early stages of Covid. Obviously, it isn't possible to treat all milds with lenzilumab. And we don't have the testing resources to test all milds to see who has elevated GM-CSF.

But testing the blood of moderates for elevated GM-CSF might not be that far away. And eventually they might be able to even test all of the mild patients. If lenz has 3-fold efficacy treating early severe patients (and under 85yo) then imagine how crazy high its efficacy would be if it treated the 10%-20% of early stage patients who have elevated GM-CSF?